Cedrik M. Britten

7.7k total citations · 1 hit paper
72 papers, 3.6k citations indexed

About

Cedrik M. Britten is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Cedrik M. Britten has authored 72 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 35 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Cedrik M. Britten's work include Immunotherapy and Immune Responses (40 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (20 papers). Cedrik M. Britten is often cited by papers focused on Immunotherapy and Immune Responses (40 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (20 papers). Cedrik M. Britten collaborates with scholars based in Germany, Netherlands and United States. Cedrik M. Britten's co-authors include Uğur Şahin, Sebastian Kreiter, Özlem Türeci, Mustafa Diken, Sylvia Janetzki, Christoph Huber, Sjoerd H. van der Burg, Marij J.P. Welters, Michael Koslowski and Cécile Gouttefangeas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Cedrik M. Britten

71 papers receiving 3.5k citations

Hit Papers

Exploiting the Mutanome for Tumor Vaccination 2012 2026 2016 2021 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exploiting the Mutanome for Tumor Vaccination
    2012 617 citations John C. Castle, Sebastian Kreiter et al. Cancer Research profile →

Peers

Cedrik M. Britten
Mireille Toebes Netherlands
Ryan Emerson United States
Erik Hooijberg Netherlands
Shahram Salek‐Ardakani United States
Jens Dannull United States
Corinne Tanchot France
Beatrice Schuler‐Thurner Germany
Hirokazu Matsushita Japan
David Boczkowski United States
Alice O. Kamphorst United States
Mireille Toebes Netherlands
Cedrik M. Britten
Citations per year, relative to Cedrik M. Britten Cedrik M. Britten (= 1×) peers Mireille Toebes

Countries citing papers authored by Cedrik M. Britten

Since Specialization
Citations

This map shows the geographic impact of Cedrik M. Britten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cedrik M. Britten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cedrik M. Britten more than expected).

Fields of papers citing papers by Cedrik M. Britten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cedrik M. Britten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cedrik M. Britten. The network helps show where Cedrik M. Britten may publish in the future.

Co-authorship network of co-authors of Cedrik M. Britten

This figure shows the co-authorship network connecting the top 25 collaborators of Cedrik M. Britten. A scholar is included among the top collaborators of Cedrik M. Britten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cedrik M. Britten. Cedrik M. Britten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mandruzzato, Susanna, Sven Brandau, Cedrik M. Britten, et al.. (2016). Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. Cancer Immunology Immunotherapy. 65(2). 161–169. 169 indexed citations
3.
Simon, Petra, Tana Omokoko, Andrea Breitkreuz, et al.. (2014). Functional TCR Retrieval from Single Antigen-Specific Human T Cells Reveals Multiple Novel Epitopes. Cancer Immunology Research. 2(12). 1230–1244. 32 indexed citations
4.
Zom, Gijs G., Selina Khan, Cedrik M. Britten, et al.. (2014). Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates. Cancer Immunology Research. 2(8). 756–764. 81 indexed citations
5.
Attig, Sebastian, Cedrik M. Britten, Henning Schulze‐Bergkamen, et al.. (2014). Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction. Cancer Immunology Immunotherapy. 63(12). 1273–1284. 1 indexed citations
6.
Castle, John C., Sebastian Kreiter, Jan Diekmann, et al.. (2012). Exploiting the Mutanome for Tumor Vaccination. Cancer Research. 72(5). 1081–1091. 617 indexed citations breakdown →
7.
Attig, Sebastian, Nicole Bidmon, Bernhard Y. Renard, et al.. (2012). Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols. Cancer Immunology Immunotherapy. 62(4). 615–627. 20 indexed citations
8.
Hoos, Axel, Sylvia Janetzki, & Cedrik M. Britten. (2012). Advancing the field of cancer immunotherapy. OncoImmunology. 1(9). 1457–1459. 4 indexed citations
9.
Welters, Marij J.P., Cécile Gouttefangeas, Tamara H. Ramwadhdoebé, et al.. (2012). Harmonization of the intracellular cytokine staining assay. Cancer Immunology Immunotherapy. 61(7). 967–978. 32 indexed citations
10.
Moodie, Zoe, Leah Price, Sylvia Janetzki, & Cedrik M. Britten. (2011). Response Determination Criteria for ELISPOT: Toward a Standard that Can Be Applied Across Laboratories. Methods in molecular biology. 792. 185–196. 42 indexed citations
11.
Kreiter, Sebastian, Abderraouf Selmi, Mustafa Diken, et al.. (2010). Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity. Cancer Research. 70(22). 9031–9040. 248 indexed citations
12.
Britten, Cedrik M., Sylvia Janetzki, Sjoerd H. van der Burg, et al.. (2010). Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunology Immunotherapy. 60(1). 15–22. 38 indexed citations
13.
Singh, Satwinder, et al.. (2010). CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26–28, 2010, Mainz, Germany. Cancer Immunology Immunotherapy. 60(3). 443–450. 2 indexed citations
14.
Britten, Cedrik M., Sylvia Janetzki, Leah Ben‐Porat, et al.. (2009). Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunology Immunotherapy. 58(10). 1701–1713. 47 indexed citations
15.
Janetzki, Sylvia, Leah Price, Cedrik M. Britten, et al.. (2009). Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells. Cancer Immunology Immunotherapy. 59(4). 609–618. 44 indexed citations
16.
Khan, Selina, Jimmy J. Weterings, Cedrik M. Britten, et al.. (2008). Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. Molecular Immunology. 46(6). 1084–1091. 54 indexed citations
17.
Meyer, Ralf G., Claudine Graf, Cedrik M. Britten, Christoph Huber, & Thomas Wölfel. (2007). Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen. Vaccine. 25(24). 4715–4722. 3 indexed citations
18.
Janetzki, Sylvia, Katherine S. Panageas, Leah Ben‐Porat, et al.. (2007). Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunology Immunotherapy. 57(3). 303–315. 150 indexed citations
19.
Britten, Cedrik M., Cécile Gouttefangeas, & Sebastian Kreiter. (2005). Cancer Immunotherapy 2005: Mainz, Germany, 12–13 May 2005. Cancer Immunology Immunotherapy. 55(4). 475–480. 1 indexed citations
20.
Vantomme, Valérie, Dirk Gheysen, Claudine Bruck, et al.. (2004). Immunologic Analysis of a Phase I/II Study of Vaccination with MAGE-3 Protein Combined with the AS02B Adjuvant in Patients with MAGE-3-Positive Tumors. Journal of Immunotherapy. 27(2). 124–135. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mireille Toebes Breakdown of academic impact, for papers by Ryan Emerson Breakdown of academic impact, for papers by Erik Hooijberg Breakdown of academic impact, for papers by Shahram Salek‐Ardakani Breakdown of academic impact, for papers by Jens Dannull Breakdown of academic impact, for papers by Corinne Tanchot Breakdown of academic impact, for papers by Beatrice Schuler‐Thurner Breakdown of academic impact, for papers by Hirokazu Matsushita Breakdown of academic impact, for papers by David Boczkowski Breakdown of academic impact, for papers by Alice O. Kamphorst
Rankless by CCL
2026